HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Egyed, M. Articles by Torday, L. Search for Related Content PubMed PubMed Citation Articles by Egyed, M. Articles by Torday, L.

Successful treatment of a primary uterine B-cell lymphoma with rituximab-CHOP immunochemotherapy

¹ Dept. of Internal Medicine, Mór Kaposi Teaching Hospital, Kaposvár, Hungary
² Dept. of Gynecology and Obstetrics, Mór Kaposi Teaching Hospital, Kaposvár, Hungary
³ Dept. of Pathology, Mór Kaposi Teaching Hospital, Kaposvár, Hungary
⁴ Diagnostic Center, Pannon Univ., Kaposvár, Hungary
⁵ Dept. of Pathology, Univ. of Pécs, Pécs, Hungary
⁶ Dept. of Oncotherapy, Univ. of Szeged, Hungary

We report the case of a 26 year old patient with a primary, Ann Arbor stage IE, diffuse large B-cell lymphoma of the uterine corpus. The patient was admitted to our hospital because of a one year history of vaginal contact bleeding. Final diagnosis was based on the histological and immunohistochemical evaluation of a specimen obtained by fractionated cervical and uterine curettage. Further staging has not revealed any other localization of the disease. Antilymphoma treatment was started with CHOP combined with rituximab and resulted complete remission. This is the first reported case of an uterine lymphoma treated by rituximab-based immunochemotherapy.

Key words: uterine lymphoma, rituximab, vaginal bleeding, immunotherapy, CHOP.